Current Consultations

Research Australia regularly contributes to the policy discussions on issues pertinent to Health and Medical Research. This can be through submissions or participating in consultations.

The following list is consultations and invitations to make submissions which are relevant to health and medical research and/or health and innovation policy in Australia. Research Australia may not participate in every one however the list is updated regularly.

If you would like more information or you are aware of other consultations that should be included, please contact Greg Mullins, Head of Policy, Research Australia via email or phone (03) 9662 9420.

Please click the heading in the left hand column to access consultation information from the relevant website.



Crowd Sourced Equity Funding- Proprietary Companies

Due 2 February 2018

Exposure draft regulations providing further detail on the extension of the crowd-sourced funding (CSF) framework to proprietary companies have been released. This is the next step in enabling proprietary companies to access equity crowdfunding, and could be used by startups in the medical innovation sector in the future as a source of funding.

The draft regulations also make refinements to the existing CSF regime for public companies, to add flexibility to the structure and contents of CSF offer documents in addition to requiring disclosure relevant to the proprietary companies, and make other minor changes to clarify the operation of the existing rules.

A Strategic Direction for Allied Health and Health Sciences Research and Knowledge Translation (WA)

Due 2 February 2018

The Western Australian Government is seeking feedback on a document designed to guide the WA health system to build the research and knowledge translation capacity of its allied health and health science professions.

The draft document is available on the website.

Review of the Australian Charities and Not for profits Commission (ACNC)

Due 28 February 2018

The Government is required to undertake a review of the Australian Charities and Not for profits Commission Act 2012 and the Australian Charities and Not-for-profits Commission (Consequential and Transitional) Act 2012 after their first five years of operation.  This review presents an opportunity to evaluate the performance of the legislative framework, the regulation of the sector and to identify any improvements that can be made.

Terms of Reference for the Review are available from the Treasury website.

Prescription opioid use and misuse in Australia

Due 2 March 2018

The TGA is undertaking a consultation on options for a regulatory response to the misuse of Schedule 8 prescription opioids.

Pharmaceutical opioid deaths in Australia now exceed heroin deaths by a significant margin – by 2-2.5 times – the reverse of what was seen in the 1990s. Between 2011 and 2015 there were 2145 deaths associated with oxycodone, morphine, codeine, fentanyl, tramadol and/or pethidine compared with 985 due to heroin. Pharmaceutical opioid deaths particularly dominate in the over 30 age group.

A consultation paper is available. Submissions may address any, or all, of the options for a regulatory response to opioid use and misuse in Australia, or other identified issues.